United States · Federal contract register · Supplier record

INTEGRAL MOLECULAR INC

Line: Health r&d services; health care services; basic research (AN11)Register loaded to September 2026Compiled 17 October 2026

INTEGRAL MOLECULAR INC — United States · Federal contract register · Supplier record: 23 contracts, all years ($33,798,354 · Aug 2008 – Sep 2026); $6.5M since January 2024 (5 contracts · 2 agencies); — rank in the line (of 283 suppliers · 0.0%); 6 agencies never served ($52.0M on the line without INTEGRAL MOLECULAR INC).

Assay record ASY-US-1MSF6VK0JY · Cite as: Assay Systems, “INTEGRAL MOLECULAR INC: 5 government contracts in the United States since 2024”, https://assay-systems.com/register/us/integral-molecular-inc/

23
contracts, all years
$33,798,354 · Aug 2008 – Sep 2026
$6.5M
since January 2024
5 contracts · 2 agencies
—
rank in the line
of 283 suppliers · 0.0%
6
agencies never served
$52.0M on the line without INTEGRAL MOLECULAR INC

Own record by year

2019 onward
$7.5M
$54.6K
$85.8K
$659K
$680K
$4.9M
$1.6M
$30.3K
20192020202120222023202420252026

Who buys from INTEGRAL MOLECULAR INC

since January 2024
2agencies
$6.5Mpaid
98.6%top buyer
Department of Health and Human Services98.6%
$6,433,855
Department of State1.4%
$91,523

Before 2024 only: Department of Defense.

Won without a rival

2023-11-20 – 2026-09-22
3uncontested awards
43%of its awards
3without a competition
0single bid

INTEGRAL MOLECULAR INC won 3 of its 7 public contract awards in United States without a rival from 2023-11-20 to 2026-09-22, worth $144K: 3 without a competition and 0 after a competition that drew a single bid. 2 buyers awarded it without a rival, the largest National Institutes of Health with 2.

Buyers: National Institutes of Health (2) · Department of State (1)

Every uncontested award of INTEGRAL MOLECULAR INC · United States: all uncontested awards

The line

since January 2024
$994Mline value
605contracts
8agencies
283suppliers
62.3%held by top ten

Health r&d services; health care services; basic research (AN11)

$570M
$195M
$229M
202420252026Jan–Sep
—of 283 suppliers
$0INTEGRAL MOLECULAR INC in the line
0.0%share of the line

Agencies that buy the line and never bought from INTEGRAL MOLECULAR INC

6agencies
181contracts
$51,956,310since January 2024
Department of Veterans Affairs166 contracts
$37,362,046
General Services Administration2 contracts
$5,967,660
Department of the Interior1 contract
$3,499,999
Department of Transportation10 contracts
$3,475,697
Department of Homeland Security1 contract
$1,646,428
Department of Justice1 contract
$4,480

How the line is bought

by value, since 2024
29%no competition
13%one applicant
0of these to INTEGRAL MOLECULAR INC
Competed, several suppliers applied319 contracts
$579,702,075 · 58.3%
Awarded directly, no competition218 contracts
$284,709,129 · 28.6%
Competed, one supplier applied68 contracts
$129,959,985 · 13.1%

Contracts reaching their end dates

Oct 2026 – October 2027
211contracts
$428,197,967end by October 2027
68end in September 2027 · $253M
69in agencies never served · $27.6M
$16.6M
$8.6M
$17.9M
$7.9M
$26.1M
$14.6M
$5.7M
$10.4M
$34.0M
$22.3M
$11.4M
$253M
Oct 269 contractsNov 266 contractsDec 2616 contractsJan 2713 contractsFeb 2716 contractsMar 2714 contractsApr 278 contractsMay 278 contractsJun 2720 contractsJul 2717 contractsAug 2716 contractsSep 2768 contracts

Suppliers next to it in the line

since January 2024
EREMID GENOMIC SERVICES LLC1 contract · 1 agency
$15,380
GENSCRIPT USA INC1 contract · 1 agency
$13,062
REGENTS OF THE UNIVERSITY OF MICHIGAN1 contract · 1 agency
$5,760
INTEGRAL MOLECULAR INC
$0

All 283 suppliers in the line

Fastest-growing supplier in the line

same line
+223%growth

Supplier UEI NVUWAFWQ57S5

2024 to Sep 2026
$112,829,431
2022–2023
$34,930,829

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.